Compounded Ozempic and Wegovy, cheaper generic versions of the weight-loss drugs, can no longer be sold. Doctor explains ...

The ruling means that small-scale compounders must immediately stop making their versions of Novo’s Ozempic and Wegovy, while ...

The decision on whether or not to use a weight loss medication is personal ... drug shortages for both tirzepatide and semaglutide, the FDA has allowed compounding pharmacies to compound these ...

A shortage of rival Novo Nordisk's (NVO) GLP-1, semaglutide, sold as Ozempic for diabetes and Wegovy for obesity, is also over. Earlier in April, Lilly took legal action against two compounding ...

An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...

As the Food and Drug Administration cracks down on compounded versions of popular weight loss drugs Wegovy (semaglutide) and Zepbound (tirzepatide), Americans who rely on these cheaper medications ...

"With the FDA announcing the resolution of shortages for Semaglutide (Wegovy, Ozempic) and Tirzepatide (Zepbound, Mounjaro), compounding pharmacies must halt production of these medications. This ...

Counterfeit forms of weight loss and diabetes drugs are ... Gower said she does not do "sterile compounding," so she doesn't compound semaglutide or tirzepatide. "The issue is that the companies ...

In 2022, the FDA announced there was a shortage of the brand-name medications, which allowed compounding pharmacies to make generic semaglutide, the main active ingredient in the weight-loss drugs.

But nearly two years after the FDA approved the use of GLP-1 drugs in kids, some are questioning if these drugs are safe for ...